| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 1.46e-05 | 15 | 65 | 3 | GO:0008494 | |
| GeneOntologyMolecularFunction | zinc ion binding | PHEX TET2 SEC24D TUT4 RC3H1 TLL1 TRIM8 CPD ZMIZ1 MMP7 ZCCHC2 EP300 | 2.63e-05 | 891 | 65 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | PHEX TET2 SEC24D TUT4 RC3H1 TLL1 TRIM8 CPD ZMIZ1 MMP7 ZCCHC2 EP300 | 4.02e-04 | 1189 | 65 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.86e-04 | 200 | 65 | 5 | GO:0008237 | |
| GeneOntologyBiologicalProcess | female meiosis II | 5.93e-07 | 6 | 65 | 3 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 5.93e-07 | 6 | 65 | 3 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 5.93e-07 | 6 | 65 | 3 | GO:0061983 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 3.53e-06 | 10 | 65 | 3 | GO:0046543 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 8.35e-06 | 13 | 65 | 3 | GO:0045136 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 1.45e-05 | 47 | 65 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 2.93e-05 | 3 | 65 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | PHEX TET2 FLI1 NCOA3 SETD2 EYA4 PDGFRB EYA1 ZMIZ1 ARID1A VPS51 EP300 GAA STAT5A | 3.28e-05 | 1269 | 65 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 7.37e-05 | 26 | 65 | 3 | GO:0045836 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 7.80e-05 | 226 | 65 | 6 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 9.12e-05 | 144 | 65 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 9.23e-05 | 75 | 65 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.03e-04 | 29 | 65 | 3 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.26e-04 | 31 | 65 | 3 | GO:0070935 | |
| GeneOntologyBiologicalProcess | cell migration involved in vasculogenesis | 1.45e-04 | 6 | 65 | 2 | GO:0035441 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine modification | 1.59e-04 | 162 | 65 | 5 | GO:0018205 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 1.59e-04 | 162 | 65 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.90e-04 | 266 | 65 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 2.15e-04 | 37 | 65 | 3 | GO:0051446 | |
| GeneOntologyBiologicalProcess | oocyte development | 2.70e-04 | 99 | 65 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 2.92e-04 | 41 | 65 | 3 | GO:0060416 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 3.14e-04 | 103 | 65 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | taurine metabolic process | 3.47e-04 | 9 | 65 | 2 | GO:0019530 | |
| GeneOntologyBiologicalProcess | alkanesulfonate metabolic process | 3.47e-04 | 9 | 65 | 2 | GO:0019694 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 3.86e-04 | 45 | 65 | 3 | GO:0040020 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 4.33e-04 | 10 | 65 | 2 | GO:0060397 | |
| GeneOntologyBiologicalProcess | chromatin organization | 4.65e-04 | 896 | 65 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 4.78e-04 | 115 | 65 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 4.78e-04 | 443 | 65 | 7 | GO:1903311 | |
| GeneOntologyBiologicalProcess | negative regulation of erythrocyte differentiation | 5.28e-04 | 11 | 65 | 2 | GO:0045647 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 5.28e-04 | 11 | 65 | 2 | GO:0070669 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 5.58e-04 | 51 | 65 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 5.91e-04 | 52 | 65 | 3 | GO:0007143 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 6.32e-04 | 12 | 65 | 2 | GO:0045588 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 6.32e-04 | 12 | 65 | 2 | GO:0032825 | |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 6.32e-04 | 12 | 65 | 2 | GO:0070672 | |
| GeneOntologyBiologicalProcess | regulation of activated T cell proliferation | 6.61e-04 | 54 | 65 | 3 | GO:0046006 | |
| GeneOntologyBiologicalProcess | female gamete generation | 6.89e-04 | 223 | 65 | 5 | GO:0007292 | |
| GeneOntologyBiologicalProcess | mucosa-associated lymphoid tissue development | 7.46e-04 | 13 | 65 | 2 | GO:0048537 | |
| GeneOntologyBiologicalProcess | Peyer's patch development | 7.46e-04 | 13 | 65 | 2 | GO:0048541 | |
| GeneOntologyBiologicalProcess | hematopoietic or lymphoid organ development | 8.25e-04 | 133 | 65 | 4 | GO:0048534 | |
| GeneOntologyBiologicalProcess | artery development | 8.25e-04 | 133 | 65 | 4 | GO:0060840 | |
| GeneOntologyBiologicalProcess | T cell homeostasis | 8.56e-04 | 59 | 65 | 3 | GO:0043029 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 8.68e-04 | 14 | 65 | 2 | GO:0046645 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 8.97e-04 | 136 | 65 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 9.94e-04 | 242 | 65 | 5 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 9.94e-04 | 242 | 65 | 5 | GO:1903708 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 1.00e-03 | 15 | 65 | 2 | GO:0045586 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.08e-03 | 999 | 65 | 10 | GO:0071824 | |
| GeneOntologyBiologicalProcess | activated T cell proliferation | 1.13e-03 | 65 | 65 | 3 | GO:0050798 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.13e-03 | 65 | 65 | 3 | GO:0045815 | |
| GeneOntologyBiologicalProcess | luteinization | 1.14e-03 | 16 | 65 | 2 | GO:0001553 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | FOXJ2 DMXL2 TUT4 TCP11X2 DAZ4 GLIPR1L1 DAZ1 ZMIZ1 DAZ2 STAT5A STAT5B | 1.17e-03 | 1194 | 65 | 11 | GO:0048609 |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.28e-03 | 382 | 65 | 6 | GO:0030217 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 1.29e-03 | 17 | 65 | 2 | GO:0046643 | |
| GeneOntologyBiologicalProcess | tube development | FOXJ2 PHEX NCOA3 SETD2 PDGFRB AMOTL1 PPP1R16B CAT EYA1 ZMIZ1 ARID1A EP300 | 1.29e-03 | 1402 | 65 | 12 | GO:0035295 |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 1.29e-03 | 68 | 65 | 3 | GO:0141137 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 1.32e-03 | 151 | 65 | 4 | GO:0045727 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 1.45e-03 | 155 | 65 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | protein sumoylation | 1.47e-03 | 71 | 65 | 3 | GO:0016925 | |
| GeneOntologyBiologicalProcess | oogenesis | 1.49e-03 | 156 | 65 | 4 | GO:0048477 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | FOXJ2 NCOA3 DMXL2 TUT4 DMRT2 TCP11X2 DAZ4 DAZ1 DAZ2 STAT5A STAT5B | 1.53e-03 | 1235 | 65 | 11 | GO:0003006 |
| GeneOntologyBiologicalProcess | cell maturation | 1.54e-03 | 267 | 65 | 5 | GO:0048469 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 1.54e-03 | 1048 | 65 | 10 | GO:0014070 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | TET2 NCOA3 SETD2 TUT4 DAZ4 U2AF2 DAZ1 DAZ2 ARID1A EP300 STAT5A STAT5B | 1.68e-03 | 1446 | 65 | 12 | GO:0010628 |
| MousePheno | abnormal thymus morphology | TET2 FLI1 PDGFRB RC3H1 TLL1 ROR1 EWSR1 CBX4 EYA1 EP300 NLK STAT5B | 2.10e-05 | 717 | 56 | 12 | MP:0000703 |
| MousePheno | abnormal gland development | 3.78e-05 | 233 | 56 | 7 | MP:0020973 | |
| Domain | EYA_fam | 6.90e-05 | 4 | 64 | 2 | IPR028472 | |
| Domain | EYA_dom | 6.90e-05 | 4 | 64 | 2 | IPR006545 | |
| Domain | RRM_1 | 7.77e-05 | 208 | 64 | 6 | PF00076 | |
| Domain | RRM | 9.81e-05 | 217 | 64 | 6 | SM00360 | |
| Domain | RRM_dom | 1.26e-04 | 227 | 64 | 6 | IPR000504 | |
| Domain | RRM | 1.35e-04 | 230 | 64 | 6 | PS50102 | |
| Domain | Nuc_rcpt_coact | 1.72e-04 | 6 | 64 | 2 | IPR009110 | |
| Domain | - | 1.86e-04 | 244 | 64 | 6 | 3.30.70.330 | |
| Domain | STAT_TF_prot_interaction | 2.40e-04 | 7 | 64 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 2.40e-04 | 7 | 64 | 2 | IPR012345 | |
| Domain | STAT | 2.40e-04 | 7 | 64 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 2.40e-04 | 7 | 64 | 2 | IPR015988 | |
| Domain | - | 2.40e-04 | 7 | 64 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 2.40e-04 | 7 | 64 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 2.40e-04 | 7 | 64 | 2 | IPR013801 | |
| Domain | STAT_bind | 2.40e-04 | 7 | 64 | 2 | PF02864 | |
| Domain | STAT_int | 2.40e-04 | 7 | 64 | 2 | PF02865 | |
| Domain | - | 2.40e-04 | 7 | 64 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 2.40e-04 | 7 | 64 | 2 | PF01017 | |
| Domain | - | 2.40e-04 | 7 | 64 | 2 | 1.20.1050.20 | |
| Domain | Nucleotide-bd_a/b_plait | 2.51e-04 | 258 | 64 | 6 | IPR012677 | |
| Domain | STAT_TF_alpha | 3.19e-04 | 8 | 64 | 2 | IPR013800 | |
| Domain | - | 5.11e-04 | 10 | 64 | 2 | 4.10.1060.10 | |
| Domain | CUB | 6.32e-04 | 49 | 64 | 3 | PF00431 | |
| Domain | CUB | 6.70e-04 | 50 | 64 | 3 | SM00042 | |
| Domain | - | 7.52e-04 | 52 | 64 | 3 | 2.60.120.290 | |
| Domain | CUB | 7.96e-04 | 53 | 64 | 3 | PS01180 | |
| Domain | CUB_dom | 9.84e-04 | 57 | 64 | 3 | IPR000859 | |
| Domain | Gal_mutarotase_SF_dom | 1.52e-03 | 17 | 64 | 2 | IPR011013 | |
| Domain | MetalloPept_cat_dom | 2.71e-03 | 81 | 64 | 3 | IPR024079 | |
| Domain | - | 2.71e-03 | 81 | 64 | 3 | 3.40.390.10 | |
| Domain | zf-CCHC | 2.79e-03 | 23 | 64 | 2 | PF00098 | |
| Domain | ZF_RANBP2_1 | 3.04e-03 | 24 | 64 | 2 | PS01358 | |
| Domain | Znf_RanBP2 | 3.30e-03 | 25 | 64 | 2 | IPR001876 | |
| Domain | - | 3.56e-03 | 26 | 64 | 2 | 4.10.60.10 | |
| Domain | ZnMc | 4.42e-03 | 29 | 64 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 4.42e-03 | 29 | 64 | 2 | IPR006026 | |
| Domain | ZINC_PROTEASE | 4.63e-03 | 98 | 64 | 3 | PS00142 | |
| Domain | VWF_A | 4.76e-03 | 99 | 64 | 3 | IPR002035 | |
| Domain | ZF_CCHC | 6.39e-03 | 35 | 64 | 2 | PS50158 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.42e-05 | 16 | 51 | 3 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.42e-05 | 16 | 51 | 3 | MM1420 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 6.54e-05 | 22 | 51 | 3 | MM1370 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 1.23e-04 | 27 | 51 | 3 | MM14712 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.27e-04 | 5 | 51 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 1.27e-04 | 5 | 51 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 1.27e-04 | 5 | 51 | 2 | M49006 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 1.53e-04 | 29 | 51 | 3 | M39616 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 1.53e-04 | 29 | 51 | 3 | M779 | |
| Pathway | WP_MALE_INFERTILITY | 1.72e-04 | 145 | 51 | 5 | M39856 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.91e-04 | 6 | 51 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.91e-04 | 6 | 51 | 2 | MM15621 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.47e-04 | 34 | 51 | 3 | MM15531 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 2.66e-04 | 7 | 51 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 2.66e-04 | 7 | 51 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 2.66e-04 | 7 | 51 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 2.66e-04 | 7 | 51 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 2.66e-04 | 7 | 51 | 2 | M27907 | |
| Pathway | WP_OVARIAN_INFERTILITY | 2.69e-04 | 35 | 51 | 3 | MM15948 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.18e-04 | 37 | 51 | 3 | M27797 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 4.55e-04 | 9 | 51 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 4.55e-04 | 9 | 51 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 4.55e-04 | 9 | 51 | 2 | M8066 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 4.61e-04 | 100 | 51 | 4 | MM15826 | |
| Pathway | PID_TCPTP_PATHWAY | 4.64e-04 | 42 | 51 | 3 | M91 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 5.67e-04 | 10 | 51 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 5.67e-04 | 10 | 51 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 5.67e-04 | 10 | 51 | 2 | MM15618 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 6.91e-04 | 11 | 51 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 6.91e-04 | 11 | 51 | 2 | MM15578 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 8.28e-04 | 12 | 51 | 2 | M27893 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 8.70e-04 | 52 | 51 | 3 | M2404 | |
| Pathway | PID_PTP1B_PATHWAY | 8.70e-04 | 52 | 51 | 3 | M50 | |
| Pathway | WP_IL4_SIGNALING | 9.72e-04 | 54 | 51 | 3 | M39720 | |
| Pathway | WP_MRNA_PROCESSING | 1.12e-03 | 451 | 51 | 7 | MM15946 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 1.14e-03 | 14 | 51 | 2 | M19193 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.14e-03 | 14 | 51 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 1.14e-03 | 14 | 51 | 2 | M135 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 1.14e-03 | 14 | 51 | 2 | MM15391 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.14e-03 | 57 | 51 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.20e-03 | 58 | 51 | 3 | M2049 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 1.26e-03 | 59 | 51 | 3 | M39350 | |
| Pathway | WP_FOXP3_IN_COVID19 | 1.31e-03 | 15 | 51 | 2 | M42573 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.31e-03 | 15 | 51 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.31e-03 | 15 | 51 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.31e-03 | 15 | 51 | 2 | M17681 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 1.31e-03 | 15 | 51 | 2 | MM14536 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.49e-03 | 16 | 51 | 2 | MM15710 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.49e-03 | 16 | 51 | 2 | M41733 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 1.59e-03 | 64 | 51 | 3 | M200 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.66e-03 | 65 | 51 | 3 | M39682 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.69e-03 | 17 | 51 | 2 | M48025 | |
| Pathway | WP_IL9_SIGNALING | 1.69e-03 | 17 | 51 | 2 | M39644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.69e-03 | 17 | 51 | 2 | M47905 | |
| Pathway | WP_AGERAGE_PATHWAY | 1.74e-03 | 66 | 51 | 3 | M39420 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 1.89e-03 | 18 | 51 | 2 | M673 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 1.89e-03 | 18 | 51 | 2 | MM15577 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 2.11e-03 | 19 | 51 | 2 | M41732 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 2.11e-03 | 19 | 51 | 2 | M12836 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 2.14e-03 | 71 | 51 | 3 | MM15947 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 2.34e-03 | 20 | 51 | 2 | MM15496 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 2.34e-03 | 20 | 51 | 2 | MM1389 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 2.34e-03 | 20 | 51 | 2 | M39002 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 2.83e-03 | 22 | 51 | 2 | M7747 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 3.09e-03 | 23 | 51 | 2 | MM1411 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 3.09e-03 | 23 | 51 | 2 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 3.09e-03 | 23 | 51 | 2 | M7897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 3.09e-03 | 23 | 51 | 2 | M47904 | |
| Pathway | PID_REG_GR_PATHWAY | 3.23e-03 | 82 | 51 | 3 | M115 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.37e-03 | 24 | 51 | 2 | M13404 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 3.37e-03 | 24 | 51 | 2 | M11520 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.37e-03 | 24 | 51 | 2 | M519 | |
| Pathway | PID_CMYB_PATHWAY | 3.46e-03 | 84 | 51 | 3 | M195 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 3.65e-03 | 25 | 51 | 2 | M41829 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 3.65e-03 | 25 | 51 | 2 | MM1519 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 3.65e-03 | 25 | 51 | 2 | M27857 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 3.65e-03 | 25 | 51 | 2 | M27865 | |
| Pathway | WP_IL7_SIGNALING | 3.65e-03 | 25 | 51 | 2 | M39499 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 3.70e-03 | 86 | 51 | 3 | M39375 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 3.95e-03 | 26 | 51 | 2 | M27750 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 3.95e-03 | 26 | 51 | 2 | M39687 | |
| Pathway | PID_IL3_PATHWAY | 3.95e-03 | 26 | 51 | 2 | M182 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 3.95e-03 | 26 | 51 | 2 | MM15896 | |
| Pathway | BIOCARTA_GH_PATHWAY | 4.25e-03 | 27 | 51 | 2 | M9043 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 4.33e-03 | 91 | 51 | 3 | M39700 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 4.52e-03 | 301 | 51 | 5 | MM15983 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 4.57e-03 | 28 | 51 | 2 | M41724 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 5.23e-03 | 30 | 51 | 2 | M207 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 5.23e-03 | 30 | 51 | 2 | M41825 | |
| Pathway | PID_IL2_STAT5_PATHWAY | 5.23e-03 | 30 | 51 | 2 | M234 | |
| Pubmed | TET2 ATXN2L NCOA3 EYA4 RESF1 RC3H1 AMOTL1 TRIM8 EWSR1 CBX4 EYA1 ZMIZ1 EP300 | 1.70e-18 | 152 | 65 | 13 | 38360978 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 14726487 | ||
| Pubmed | High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. | 6.23e-09 | 3 | 65 | 3 | 11870237 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.91e-08 | 351 | 65 | 9 | 38297188 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 2.49e-08 | 4 | 65 | 3 | 15066457 | |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 7670487 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 11694340 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 9321470 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 19223287 | ||
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 2.49e-08 | 4 | 65 | 3 | 11095434 | |
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 2.49e-08 | 4 | 65 | 3 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 2.49e-08 | 4 | 65 | 3 | 11688365 | |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 2.49e-08 | 4 | 65 | 3 | 11883873 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 2.49e-08 | 4 | 65 | 3 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 2.49e-08 | 4 | 65 | 3 | 16963411 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 2.49e-08 | 4 | 65 | 3 | 12801575 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.59e-08 | 398 | 65 | 9 | 35016035 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 23579190 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 6.21e-08 | 5 | 65 | 3 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 6.21e-08 | 5 | 65 | 3 | 9288969 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 20008336 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 6.21e-08 | 5 | 65 | 3 | 8679003 | |
| Pubmed | TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma. | 6.21e-08 | 5 | 65 | 3 | 34329586 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 6.21e-08 | 5 | 65 | 3 | 10903443 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 6.21e-08 | 5 | 65 | 3 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 6.21e-08 | 5 | 65 | 3 | 8845845 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 6.21e-08 | 5 | 65 | 3 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 6.21e-08 | 5 | 65 | 3 | 19783541 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 22293198 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 17761180 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 6.21e-08 | 5 | 65 | 3 | 12200456 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 11514340 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 11089564 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 6.21e-08 | 5 | 65 | 3 | 22223682 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 6.21e-08 | 5 | 65 | 3 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 6.21e-08 | 5 | 65 | 3 | 8968756 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 6.21e-08 | 5 | 65 | 3 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 6.21e-08 | 5 | 65 | 3 | 26411291 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 6.21e-08 | 5 | 65 | 3 | 23223451 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 34985827 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 11804965 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 6.21e-08 | 5 | 65 | 3 | 14648873 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 8896558 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 9700189 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 21270429 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 8661148 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 1.24e-07 | 6 | 65 | 3 | 15066460 | |
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 1.24e-07 | 6 | 65 | 3 | 18452650 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 1.24e-07 | 6 | 65 | 3 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 1.24e-07 | 6 | 65 | 3 | 31355046 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 1.24e-07 | 6 | 65 | 3 | 23417416 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 32170089 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 16278232 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 20157580 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 17219433 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 1.24e-07 | 6 | 65 | 3 | 26077710 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 1.24e-07 | 6 | 65 | 3 | 16001084 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 32962040 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 17526644 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 1.24e-07 | 6 | 65 | 3 | 1869307 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 11390979 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 27632217 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 1.24e-07 | 6 | 65 | 3 | 14611632 | |
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 10857750 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 11410654 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 15081113 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 22699423 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 11604102 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 2.17e-07 | 7 | 65 | 3 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 2.17e-07 | 7 | 65 | 3 | 26826184 | |
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 2.17e-07 | 7 | 65 | 3 | 16946704 | |
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 10951504 | ||
| Pubmed | Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. | 3.47e-07 | 8 | 65 | 3 | 9989503 | |
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 3.47e-07 | 8 | 65 | 3 | 32339196 | |
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 3.47e-07 | 8 | 65 | 3 | 23204224 | |
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 29883445 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 10823932 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 22621333 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 32686646 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 11869379 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 5.19e-07 | 9 | 65 | 3 | 16310179 | |
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 9484840 | ||
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 20159962 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 5.19e-07 | 9 | 65 | 3 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 5.19e-07 | 9 | 65 | 3 | 19695304 | |
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 28235998 | ||
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 10601091 | ||
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 7.41e-07 | 10 | 65 | 3 | 14648882 | |
| Interaction | EYA4 interactions | FOXJ2 TET2 ATXN2L NCOA3 EYA4 RESF1 SUPT5H RC3H1 AMOTL1 TRIM8 EWSR1 CBX4 EYA1 ZMIZ1 EP300 | 7.84e-16 | 243 | 63 | 15 | int:EYA4 |
| Interaction | ETS2 interactions | 3.55e-08 | 61 | 63 | 6 | int:ETS2 | |
| Interaction | ETV4 interactions | 7.52e-08 | 69 | 63 | 6 | int:ETV4 | |
| Interaction | SOX7 interactions | 2.13e-07 | 82 | 63 | 6 | int:SOX7 | |
| Interaction | EGR2 interactions | 1.04e-06 | 171 | 63 | 7 | int:EGR2 | |
| Interaction | CRX interactions | 1.21e-06 | 254 | 63 | 8 | int:CRX | |
| Interaction | R3HDM2 interactions | 3.08e-06 | 129 | 63 | 6 | int:R3HDM2 | |
| Interaction | STAT5A interactions | 3.37e-06 | 131 | 63 | 6 | int:STAT5A | |
| Interaction | ERG interactions | 6.04e-06 | 223 | 63 | 7 | int:ERG | |
| Interaction | DAZL interactions | 6.06e-06 | 145 | 63 | 6 | int:DAZL | |
| Interaction | SEC24A interactions | 6.22e-06 | 224 | 63 | 7 | int:SEC24A | |
| Interaction | PGR interactions | 6.48e-06 | 84 | 63 | 5 | int:PGR | |
| Interaction | CPSF7 interactions | 1.00e-05 | 338 | 63 | 8 | int:CPSF7 | |
| Interaction | NCOR2 interactions | 1.81e-05 | 264 | 63 | 7 | int:NCOR2 | |
| Interaction | TLE3 interactions | 2.16e-05 | 376 | 63 | 8 | int:TLE3 | |
| Interaction | ALG13 interactions | 2.28e-05 | 183 | 63 | 6 | int:ALG13 | |
| Interaction | SMARCC1 interactions | 2.51e-05 | 384 | 63 | 8 | int:SMARCC1 | |
| Interaction | TBR1 interactions | 2.75e-05 | 113 | 63 | 5 | int:TBR1 | |
| Interaction | HNF1B interactions | 2.82e-05 | 190 | 63 | 6 | int:HNF1B | |
| Interaction | QKI interactions | 2.82e-05 | 190 | 63 | 6 | int:QKI | |
| Interaction | CPSF6 interactions | 3.55e-05 | 526 | 63 | 9 | int:CPSF6 | |
| Interaction | ETS1 interactions | 3.82e-05 | 121 | 63 | 5 | int:ETS1 | |
| Interaction | TAF15 interactions | 3.86e-05 | 408 | 63 | 8 | int:TAF15 | |
| Interaction | UBAP2L interactions | 3.92e-05 | 298 | 63 | 7 | int:UBAP2L | |
| Interaction | SP7 interactions | 4.45e-05 | 304 | 63 | 7 | int:SP7 | |
| Interaction | SEC24C interactions | 4.56e-05 | 207 | 63 | 6 | int:SEC24C | |
| Interaction | PAX9 interactions | 5.38e-05 | 130 | 63 | 5 | int:PAX9 | |
| Interaction | BICRA interactions | 5.73e-05 | 67 | 63 | 4 | int:BICRA | |
| Interaction | GCM1 interactions | 6.08e-05 | 68 | 63 | 4 | int:GCM1 | |
| Interaction | TLE6 interactions | 6.38e-05 | 25 | 63 | 3 | int:TLE6 | |
| Interaction | BCLAF1 interactions | 7.05e-05 | 327 | 63 | 7 | int:BCLAF1 | |
| Interaction | SMAD3 interactions | 7.32e-05 | 447 | 63 | 8 | int:SMAD3 | |
| Interaction | SOX15 interactions | 7.92e-05 | 141 | 63 | 5 | int:SOX15 | |
| Interaction | MAML1 interactions | 8.03e-05 | 73 | 63 | 4 | int:MAML1 | |
| Interaction | FAM168A interactions | 8.19e-05 | 142 | 63 | 5 | int:FAM168A | |
| Interaction | TRPS1 interactions | 8.47e-05 | 143 | 63 | 5 | int:TRPS1 | |
| Interaction | NCOA1 interactions | 9.34e-05 | 146 | 63 | 5 | int:NCOA1 | |
| Interaction | SOX2 interactions | TET2 ATXN2L FLI1 NCOA3 SETD2 SUPT5H RBFOX1 SEC16A CAT EWSR1 CBX4 EYA1 ARID1A EP300 | 1.00e-04 | 1422 | 63 | 14 | int:SOX2 |
| Interaction | PRMT1 interactions | TET2 ATXN2L NCOA3 EYA4 SUPT5H SEC16A U2AF2 CAT EWSR1 EP300 STAT5A | 1.28e-04 | 929 | 63 | 11 | int:PRMT1 |
| Interaction | HELZ interactions | 1.50e-04 | 257 | 63 | 6 | int:HELZ | |
| Interaction | GSC interactions | 1.59e-04 | 87 | 63 | 4 | int:GSC | |
| Interaction | FOXI1 interactions | 1.97e-04 | 92 | 63 | 4 | int:FOXI1 | |
| Interaction | KLF1 interactions | 2.10e-04 | 37 | 63 | 3 | int:KLF1 | |
| Interaction | FAM222B interactions | 3.06e-04 | 42 | 63 | 3 | int:FAM222B | |
| Interaction | BOLL interactions | 3.06e-04 | 42 | 63 | 3 | int:BOLL | |
| Interaction | ATXN1 interactions | ATXN2L SETD2 SUPT5H RBFOX1 HSFX1 U2AF2 PYGL DAZ2 ARID1A GAA NLK | 3.39e-04 | 1039 | 63 | 11 | int:ATXN1 |
| Interaction | NUP35 interactions | 3.48e-04 | 424 | 63 | 7 | int:NUP35 | |
| Interaction | KLF5 interactions | 3.59e-04 | 195 | 63 | 5 | int:KLF5 | |
| Interaction | SF1 interactions | 3.70e-04 | 304 | 63 | 6 | int:SF1 | |
| Interaction | RORC interactions | 3.76e-04 | 45 | 63 | 3 | int:RORC | |
| Interaction | RARB interactions | 4.02e-04 | 46 | 63 | 3 | int:RARB | |
| Interaction | MRTO4 interactions | 4.04e-04 | 200 | 63 | 5 | int:MRTO4 | |
| Interaction | PAX8 interactions | 4.04e-04 | 111 | 63 | 4 | int:PAX8 | |
| Interaction | PDHX interactions | 4.18e-04 | 112 | 63 | 4 | int:PDHX | |
| Interaction | EDEM1 interactions | 4.22e-04 | 202 | 63 | 5 | int:EDEM1 | |
| Interaction | EWSR1 interactions | 4.70e-04 | 906 | 63 | 10 | int:EWSR1 | |
| Interaction | CNOT3 interactions | 4.72e-04 | 207 | 63 | 5 | int:CNOT3 | |
| Interaction | EPOR interactions | 5.14e-04 | 50 | 63 | 3 | int:EPOR | |
| Interaction | CARM1 interactions | 5.27e-04 | 325 | 63 | 6 | int:CARM1 | |
| Interaction | CREBBP interactions | 5.34e-04 | 599 | 63 | 8 | int:CREBBP | |
| Interaction | MECP2 interactions | CYC1 ATXN2L SETD2 DMXL2 SUPT5H RBFOX1 U2AF2 CAT EWSR1 CBX4 ARID1A EP300 | 5.59e-04 | 1287 | 63 | 12 | int:MECP2 |
| Interaction | EYA2 interactions | 5.60e-04 | 121 | 63 | 4 | int:EYA2 | |
| Interaction | SMARCA4 interactions | 5.81e-04 | 462 | 63 | 7 | int:SMARCA4 | |
| Interaction | PAX7 interactions | 6.14e-04 | 124 | 63 | 4 | int:PAX7 | |
| Interaction | STAT5B interactions | 6.33e-04 | 125 | 63 | 4 | int:STAT5B | |
| Interaction | DCAF6 interactions | 6.35e-04 | 221 | 63 | 5 | int:DCAF6 | |
| Interaction | MEX3B interactions | 6.48e-04 | 222 | 63 | 5 | int:MEX3B | |
| Interaction | PRMT5 interactions | 6.51e-04 | 471 | 63 | 7 | int:PRMT5 | |
| Interaction | RARA interactions | 6.62e-04 | 223 | 63 | 5 | int:RARA | |
| Interaction | SRSF9 interactions | 6.75e-04 | 224 | 63 | 5 | int:SRSF9 | |
| Interaction | FIP1L1 interactions | 6.89e-04 | 225 | 63 | 5 | int:FIP1L1 | |
| Interaction | FHL1 interactions | 7.13e-04 | 129 | 63 | 4 | int:FHL1 | |
| Interaction | KHDC4 interactions | 7.17e-04 | 56 | 63 | 3 | int:KHDC4 | |
| Interaction | PDGFRB interactions | 7.31e-04 | 228 | 63 | 5 | int:PDGFRB | |
| Interaction | FOXC1 interactions | 7.31e-04 | 228 | 63 | 5 | int:FOXC1 | |
| Cytoband | 17q11.2 | 1.89e-05 | 110 | 65 | 4 | 17q11.2 | |
| Cytoband | Yq11.223 | 3.21e-04 | 93 | 65 | 3 | Yq11.223 | |
| Cytoband | 5q33.1 | 6.28e-04 | 26 | 65 | 2 | 5q33.1 | |
| Cytoband | 1p32.3 | 3.42e-03 | 61 | 65 | 2 | 1p32.3 | |
| GeneFamily | RNA binding motif containing | 1.06e-05 | 213 | 43 | 6 | 725 | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 3.31e-05 | 4 | 43 | 2 | 1044 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.35e-04 | 17 | 43 | 2 | 486 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 1.60e-03 | 25 | 43 | 2 | 74 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.07e-03 | 40 | 43 | 2 | 321 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 2.87e-06 | 12 | 63 | 3 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 2.87e-06 | 12 | 63 | 3 | MM781 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP | 8.42e-06 | 199 | 63 | 6 | M7951 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 8.66e-06 | 200 | 63 | 6 | M6090 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 2.26e-05 | 23 | 63 | 3 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 5.67e-05 | 31 | 63 | 3 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 6.86e-05 | 33 | 63 | 3 | MM701 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.36e-05 | 180 | 63 | 5 | M8239 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | 7.97e-05 | 433 | 63 | 7 | M2240 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP | 1.21e-04 | 200 | 63 | 5 | M5134 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 1.21e-04 | 200 | 63 | 5 | M3277 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 4.11e-06 | 36 | 64 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | EYA4 SLITRK2 TLL1 ROR1 RBFOX1 CPD EYA1 ZMIZ1 CSMD3 STAT5A STAT5B | 2.98e-05 | 818 | 64 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CPNE8 EYA4 PDGFRB TLL1 ROR1 RBFOX1 CPD EYA1 ZMIZ1 STAT5A STAT5B | 2.98e-05 | 818 | 64 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_200 | 3.22e-05 | 60 | 64 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#1_top-relative-expression-ranked_500 | 4.16e-05 | 64 | 64 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 4.28e-05 | 429 | 64 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#2_top-relative-expression-ranked_500 | 7.77e-05 | 75 | 64 | 4 | gudmap_developingKidney_e11.5_metaneph mesench_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.06e-04 | 250 | 64 | 6 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#2_top-relative-expression-ranked_100 | 1.11e-04 | 31 | 64 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_100_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.34e-04 | 261 | 64 | 6 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 1.39e-04 | 806 | 64 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_200 | 1.61e-04 | 170 | 64 | 5 | gudmap_developingKidney_e13.5_podocyte cells_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.65e-04 | 91 | 64 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_200 | 1.85e-04 | 175 | 64 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 1.87e-04 | 836 | 64 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | 2.24e-04 | 855 | 64 | 10 | gudmap_developingKidney_e13.5_podocyte cells_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.91e-04 | 193 | 64 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 2.93e-04 | 427 | 64 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 2.97e-04 | 428 | 64 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 3.10e-04 | 431 | 64 | 7 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.51e-04 | 312 | 64 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.59e-04 | 202 | 64 | 5 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.72e-04 | 744 | 64 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 6.34e-04 | 801 | 64 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.35e-04 | 229 | 64 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 6.63e-04 | 806 | 64 | 9 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 197 | 65 | 5 | 88859b7b24b36afab4a684fd7abf0e0f8e5b525c | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.10e-05 | 200 | 65 | 5 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.10e-05 | 200 | 65 | 5 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.19e-05 | 157 | 65 | 4 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.39e-05 | 158 | 65 | 4 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.02e-04 | 166 | 65 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 166 | 65 | 4 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 166 | 65 | 4 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 168 | 65 | 4 | 271a81c59a9a75bac6107c68fead03e7f35bc192 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 168 | 65 | 4 | b220e732eb7b204fc263a9f2e8ddae6bf9fa98f4 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 171 | 65 | 4 | 2dfed6e9ac89adb2501a1a5e1ca895f49190562d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-plasmacytoid_dendritic_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 171 | 65 | 4 | 2aaae0229c3a13d0275a03a3d576db650c2bf2c0 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 173 | 65 | 4 | 8fb32a9f2dbec16de840d55b4db7e7718f5a2a7a | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 173 | 65 | 4 | f663571aaae2365660a8b526c355f4bd1a124a74 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 174 | 65 | 4 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 175 | 65 | 4 | c1a8a55af825d5913095f919fa860828df9c273e | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 175 | 65 | 4 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 175 | 65 | 4 | 78b453e220218c84557f244ef7a760e4a1952761 | |
| ToppCell | facs-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 177 | 65 | 4 | 17065d37fd41f04f67282bee00365daa185e8355 | |
| ToppCell | facs-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 177 | 65 | 4 | 6e45e1a5a894ca2e4ebc5cdb17fdf79e9e188185 | |
| ToppCell | facs-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 177 | 65 | 4 | 9ff3a77c5c62c8a950c46ca22cd7bde425b84c9a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 178 | 65 | 4 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 179 | 65 | 4 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 180 | 65 | 4 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-04 | 181 | 65 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 183 | 65 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-04 | 183 | 65 | 4 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 186 | 65 | 4 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 187 | 65 | 4 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.67e-04 | 189 | 65 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.71e-04 | 190 | 65 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 191 | 65 | 4 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.74e-04 | 191 | 65 | 4 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 191 | 65 | 4 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.78e-04 | 192 | 65 | 4 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-04 | 192 | 65 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.81e-04 | 193 | 65 | 4 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | severe-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.81e-04 | 193 | 65 | 4 | f4d43dfbf4115dd0f843ea5cf08049220342a047 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 193 | 65 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 193 | 65 | 4 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.81e-04 | 193 | 65 | 4 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-04 | 193 | 65 | 4 | 02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.85e-04 | 194 | 65 | 4 | efd5efed060edb7f24d59600981bb60ec28ac2ef | |
| ToppCell | severe-Myeloid-Neutrophils_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.85e-04 | 194 | 65 | 4 | 1f8edab1c8ba48bc0114429ea47aab378b5830b7 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.85e-04 | 194 | 65 | 4 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.85e-04 | 194 | 65 | 4 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.92e-04 | 196 | 65 | 4 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 196 | 65 | 4 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 196 | 65 | 4 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.92e-04 | 196 | 65 | 4 | 81278e696d823744267d6315c4d42799c4ea0b2c | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 1.96e-04 | 197 | 65 | 4 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.96e-04 | 197 | 65 | 4 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 198 | 65 | 4 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 198 | 65 | 4 | de5987588b9fa9ee8c595ba06d7d844ead0e3c74 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.00e-04 | 198 | 65 | 4 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | COVID-19_Severe-Neu_1|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 2.00e-04 | 198 | 65 | 4 | bbe639ea5a636c985e509fb0a133ae3b60afac5a | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 198 | 65 | 4 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 198 | 65 | 4 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-04 | 199 | 65 | 4 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-OPC_related-OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-04 | 199 | 65 | 4 | c0dc14fb9899d4263264347436de121814441dfb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-04 | 199 | 65 | 4 | 9bc53ff93ca97af4ee0f01c74a567987a26abb18 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.08e-04 | 200 | 65 | 4 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35 | |
| ToppCell | control-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | 251ca08fab5cc2a4e280db6a6286a9ebaef3e61a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 200 | 65 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.08e-04 | 200 | 65 | 4 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 81 | 65 | 3 | 8cb94dda18010b3b05e5ab72235850483013c03a | |
| Drug | boron trichloride | 4.41e-07 | 6 | 65 | 3 | CID000025135 | |
| Drug | kt S | 1.27e-06 | 66 | 65 | 5 | CID006399216 | |
| Drug | propham | 7.54e-06 | 44 | 65 | 4 | CID000024685 | |
| Drug | bipy | 8.53e-06 | 97 | 65 | 5 | CID000001474 | |
| Drug | pirimiphos methyl | 1.18e-05 | 178 | 65 | 6 | ctd:C014153 | |
| Drug | desmethylazelastine | 1.21e-05 | 16 | 65 | 3 | CID000162558 | |
| Drug | dazmegrel | 2.08e-05 | 19 | 65 | 3 | CID000053555 | |
| Drug | YM 026 | 2.08e-05 | 19 | 65 | 3 | CID000004443 | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 4545_UP | |
| Drug | d 1b | 2.98e-05 | 62 | 65 | 4 | CID000449090 | |
| Drug | AZFd | 3.78e-05 | 23 | 65 | 3 | CID000196489 | |
| Drug | dansylaziridine | 3.78e-05 | 23 | 65 | 3 | CID000104008 | |
| Drug | AZD 1480 | 4.80e-05 | 4 | 65 | 2 | ctd:C545606 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 3.05e-07 | 28 | 60 | 4 | DOID:3717 (is_marker_for) | |
| Disease | Male sterility due to Y-chromosome deletions | 4.44e-07 | 8 | 60 | 3 | C2931163 | |
| Disease | Partial chromosome Y deletion | 4.44e-07 | 8 | 60 | 3 | C1507149 | |
| Disease | T-Cell Lymphoma | 4.39e-06 | 16 | 60 | 3 | C0079772 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.30e-05 | 148 | 60 | 5 | C0279702 | |
| Disease | myeloproliferative neoplasm (is_implicated_in) | 2.43e-05 | 4 | 60 | 2 | DOID:2226 (is_implicated_in) | |
| Disease | Extra-osseous Ewing's sarcoma | 2.43e-05 | 4 | 60 | 2 | C0279980 | |
| Disease | posterior thigh muscle fat infiltration measurement | 4.99e-05 | 35 | 60 | 3 | EFO_0020934 | |
| Disease | Malignant neoplasm of breast | 5.64e-05 | 1074 | 60 | 10 | C0006142 | |
| Disease | Leukemia, Myelomonocytic, Chronic | 6.07e-05 | 6 | 60 | 2 | C0023480 | |
| Disease | eye disease (implicated_via_orthology) | 6.07e-05 | 6 | 60 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 8.48e-05 | 7 | 60 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | Kidney Calculi | 8.48e-05 | 7 | 60 | 2 | C0022650 | |
| Disease | Breast Carcinoma | 1.08e-04 | 538 | 60 | 7 | C0678222 | |
| Disease | Ewings sarcoma | 1.13e-04 | 8 | 60 | 2 | C0553580 | |
| Disease | Embryonal Rhabdomyosarcoma | 1.13e-04 | 8 | 60 | 2 | C0206656 | |
| Disease | Colorectal Neoplasms | 2.52e-04 | 277 | 60 | 5 | C0009404 | |
| Disease | Fetal Alcohol Spectrum Disorders | 3.13e-04 | 13 | 60 | 2 | C2985290 | |
| Disease | breast carcinoma (is_marker_for) | 3.34e-04 | 66 | 60 | 3 | DOID:3459 (is_marker_for) | |
| Disease | schizophrenia (implicated_via_orthology) | 3.65e-04 | 68 | 60 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Replication Error Phenotype | 4.20e-04 | 15 | 60 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 4.20e-04 | 15 | 60 | 2 | C0920269 | |
| Disease | neutrophil count | FOXJ2 TET2 SETD2 EYA4 SUPT5H RC3H1 RBFOX1 ZMIZ1 ZCCHC2 ARID1A | 4.37e-04 | 1382 | 60 | 10 | EFO_0004833 |
| Disease | albumin:globulin ratio measurement | 4.49e-04 | 73 | 60 | 3 | EFO_0005128 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 4.79e-04 | 16 | 60 | 2 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 4.79e-04 | 16 | 60 | 2 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 4.79e-04 | 16 | 60 | 2 | cv:C1839071 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.11e-04 | 181 | 60 | 4 | DOID:684 (is_implicated_in) | |
| Disease | Fetal Alcohol Syndrome | 5.42e-04 | 17 | 60 | 2 | C0015923 | |
| Disease | Nonsyndromic Deafness | 6.09e-04 | 81 | 60 | 3 | C3711374 | |
| Disease | Mammary Carcinoma, Human | 6.84e-04 | 525 | 60 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 6.84e-04 | 525 | 60 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 6.98e-04 | 527 | 60 | 6 | C1458155 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 7.42e-04 | 200 | 60 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | waist-hip ratio | 7.85e-04 | 1226 | 60 | 9 | EFO_0004343 | |
| Disease | Granulomatous Slack Skin | 9.15e-04 | 22 | 60 | 2 | C0376407 | |
| Disease | otitis media (implicated_via_orthology) | 9.15e-04 | 22 | 60 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | Lymphoma, T-Cell, Cutaneous | 1.00e-03 | 23 | 60 | 2 | C0079773 | |
| Disease | Seizures | 1.02e-03 | 218 | 60 | 4 | C0036572 | |
| Disease | hearing impairment | 1.06e-03 | 98 | 60 | 3 | C1384666 | |
| Disease | Adenoid Cystic Carcinoma | 1.12e-03 | 100 | 60 | 3 | C0010606 | |
| Disease | unipolar depression, schizophrenia | 1.18e-03 | 25 | 60 | 2 | EFO_0003761, MONDO_0005090 | |
| Disease | hypertension (biomarker_via_orthology) | 1.19e-03 | 227 | 60 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.28e-03 | 26 | 60 | 2 | DOID:234 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.29e-03 | 398 | 60 | 5 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Glycogen Storage Disease | 1.38e-03 | 27 | 60 | 2 | C0017919 | |
| Disease | Sezary Syndrome | 1.38e-03 | 27 | 60 | 2 | C0036920 | |
| Disease | congestive heart failure (is_implicated_in) | 1.38e-03 | 27 | 60 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | uric acid measurement | 1.48e-03 | 610 | 60 | 6 | EFO_0004761 | |
| Disease | neutrophil percentage of leukocytes | 1.48e-03 | 610 | 60 | 6 | EFO_0007990 | |
| Disease | anterior thigh muscle fat infiltration measurement | 1.49e-03 | 28 | 60 | 2 | EFO_0020936 | |
| Disease | Carcinoma, Granular Cell | 1.72e-03 | 116 | 60 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.72e-03 | 116 | 60 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.72e-03 | 116 | 60 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.72e-03 | 116 | 60 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.72e-03 | 116 | 60 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.72e-03 | 116 | 60 | 3 | C0001418 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPAYPAYGQQPAATA | 121 | Q01844 | |
| MMNNPNPYGSPYTQN | 246 | Q09472 | |
| SPGYPDSYPNLQMCA | 2471 | Q7Z407 | |
| PMCMQDNQGGAPNYY | 391 | P04040 | |
| LTSPEYPNNYPNSME | 156 | Q5VXM1 | |
| GNGQPANMPEYNAPA | 651 | Q8IY63 | |
| MDQFEGPPPNYINTY | 2561 | Q8TDJ6 | |
| YFPGQAIAMAPPIYT | 236 | P08574 | |
| HVYNYQMPPQCPVGE | 521 | Q13117 | |
| PQMYPYPVSNSVPGQ | 726 | Q8WWM7 | |
| APYQQGMYYTPPPQC | 606 | Q5TC82 | |
| SGMYSPSRYPPQQQQ | 1316 | O14497 | |
| SDPNAVMYPTYGNGD | 226 | P09237 | |
| NDNPPQMSQAVFYPS | 1131 | Q9NYQ8 | |
| LMPNPPLYYQPGNDQ | 321 | Q6ZU69 | |
| LMPNPPLYYQPGNDQ | 51 | Q63HN1 | |
| STPQPGQAPYSYQMQ | 171 | Q99502 | |
| MYPIPTQDSAGYNRP | 531 | Q9P0K8 | |
| AAAMLNPGQQQPYFP | 81 | Q9UBE8 | |
| PDNANVFYAMSPVAP | 676 | Q3MIN7 | |
| YPGDNATPEQMAQYA | 36 | P01298 | |
| PDYSMAYGNPGVADA | 451 | Q96T49 | |
| FSTPQPGQTPYSYQM | 226 | O95677 | |
| FHVYNYQMPPQCPVG | 706 | Q9NQZ3 | |
| PNRMVPGPDYNSYKS | 271 | Q9Y5R5 | |
| NTAPAYQPPAAYKDN | 206 | O95500 | |
| NPDAYDYNKAQVPGP | 591 | Q9H8Y5 | |
| DQGPVPGNTPIMYYC | 511 | Q9NY28 | |
| NYNSYMDEKNGPPPP | 101 | Q01543 | |
| PYQPDPKMYDLQYQG | 161 | O00257 | |
| QGRPCKNMYPNEYFP | 716 | O75976 | |
| PQEPYSFSEPAQQAM | 681 | P10253 | |
| NAEGPPAMLPYYTVN | 81 | P49641 | |
| YGPAGNFANMPPYVR | 171 | Q6UWM5 | |
| FHVYNYQMPPQCPVG | 541 | Q86SG3 | |
| YPPGYAFDVEAMNFP | 576 | P20648 | |
| GNPAQPTSLHYMNPY | 321 | Q86YQ8 | |
| FPMGYAAAAPAYSPN | 26 | A1KXE4 | |
| AAAAPAYSPNMYPGA | 31 | A1KXE4 | |
| AYSPNMYPGANPTFQ | 36 | A1KXE4 | |
| GTPYPELPMNEQFYN | 901 | P09619 | |
| MPASDGPQAYPDYAD | 406 | Q9UBD0 | |
| MAQPYASAQFAPPQN | 21 | Q9NWB1 | |
| GQIQSPNYPDDYRPM | 471 | O43897 | |
| NSEPPSPTMVLYQGY | 186 | Q5H9J9 | |
| SYPGSNQEACMYPGN | 41 | Q9HCM1 | |
| AMSYLTSYQPPQNPY | 631 | Q06033 | |
| YQPNYGMGQQPDPAF | 1311 | Q9Y6Q9 | |
| DGHVYNYIPPPVGQM | 681 | Q9H156 | |
| PQAHYNMYPQNPDSV | 736 | P51692 | |
| NPQYNPQTPGTPAMY | 871 | O00267 | |
| MSQQGYVATPPYSQP | 1 | O94855 | |
| SPAVCPQAPYNMYPQ | 726 | P42229 | |
| PQAPYNMYPQNPDHV | 731 | P42229 | |
| NLQLNSYYYPNPMPG | 1026 | Q9C0B9 | |
| LSNPRYPNYMFPSQG | 781 | Q01973 | |
| YPNYMFPSQGITPQG | 786 | Q01973 | |
| QQGRYAPSYTPSAPM | 656 | Q9UID3 | |
| PSGAMPFYNPAQLAQ | 2321 | O15027 | |
| NNPIPEDMPSYGVYP | 91 | P78562 | |
| AAPTAVYYMPEPQSG | 201 | A0A0J9YWL9 | |
| YPMQAYVDPSNPNAG | 2171 | Q9BYW2 | |
| YNYPVPVRDDGNMPD | 51 | O95167 | |
| DYQPLPGMSENPSVY | 231 | P26368 | |
| QPYGASQYLPNPMAA | 11 | A8MV65 | |
| YPNGSAAQQPMLPQY | 446 | Q9BZR9 | |
| MPLYNFPQSPPAQYS | 1471 | Q5TAX3 | |
| GSYLNSSNPMNPYPG | 1606 | Q6N021 | |
| PYDTPVPGYMNNTVN | 226 | P06737 | |
| YNSQFMNQPGPRGPA | 326 | Q9ULJ6 | |
| NIVPPYNAFSAQGMP | 146 | Q9Y3Q0 |